TRCT
ANGO icon

Tower Research Capital (TRC)’s AngioDynamics ANGO Stock Holding History

Tower Research Capital (TRC)’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16K Buy
1,405
+86
+7% +$932 ﹤0.01% 3642
2025
Q4 		$16.9K Sell
1,319
-458
-26% -$5.65K ﹤0.01% 3226
2025
Q3 		$19.8K Sell
1,777
-3,680
-67% -$35.5K ﹤0.01% 3316
2025
Q2 		$54.1K Buy
5,457
+4,268
+359% +$41.8K ﹤0.01% 2908
2025
Q1 		$11.2K Buy
1,189
+467
+65% +$4.91K ﹤0.01% 3563
2024
Q4 		$6.61K Sell
722
-2,826
-80% -$20.8K ﹤0.01% 4158
2024
Q3 		$27.6K Sell
3,548
-975
-22% -$7.04K ﹤0.01% 3061
2024
Q2 		$27.4K Buy
4,523
+1,176
+35% +$7.26K ﹤0.01% 3554
2024
Q1 		$19.6K Sell
3,347
-10,436
-76% -$62K ﹤0.01% 3016
2023
Q4 		$108K Buy
13,783
+11,924
+641% +$82.7K ﹤0.01% 2595
2023
Q3 		$13.6K Buy
1,859
+805
+76% +$6.7K ﹤0.01% 3770
2023
Q2 		$11K Sell
1,054
-5,197
-83% -$50K ﹤0.01% 4035
2023
Q1 		$65K Sell
6,251
-3,816
-38% -$48.8K ﹤0.01% 2262
2022
Q4 		$139K Buy
10,067
+5,625
+127% +$78.3K 0.01% 1572
2022
Q3 		$91K Buy
4,442
+2,895
+187% +$63.6K ﹤0.01% 2641
2022
Q2 		$30K Sell
1,547
-11,414
-88% -$234K ﹤0.01% 3367
2022
Q1 		$279K Buy
12,961
+12,388
+2,162% +$281K ﹤0.01% 1505
2021
Q4 		$16K Sell
573
-2,383
-81% -$65.8K ﹤0.01% 3899
2021
Q3 		$77K Buy
2,956
+1,877
+174% +$50.2K ﹤0.01% 2619
2021
Q2 		$29K Sell
1,079
-5,485
-84% -$134K ﹤0.01% 3511
2021
Q1 		$154K Buy
6,564
+3,619
+123% +$73.1K ﹤0.01% 2225
2020
Q4 		$45K Sell
2,945
-36,386
-93% -$462K ﹤0.01% 3208
2020
Q3 		$475K Buy
39,331
+32,197
+451% +$306K 0.01% 1733
2020
Q2 		$73K Buy
+7,134
New +$73.5K ﹤0.01% 2738
2019
Q4 		– Sell
-866
Closed -$16K – 3484
2019
Q3 		$16K Sell
866
-200
-19% -$3.91K ﹤0.01% 2602
2019
Q2 		$21K Buy
+1,066
New +$21.7K ﹤0.01% 2140
2019
Q1 		– Sell
-1,270
Closed -$26K – 3752
2018
Q4 		$26K Buy
1,270
+1,170
+1,170% +$24.2K ﹤0.01% 1727
2018
Q3 		$2K Sell
100
-927
-90% -$20.6K ﹤0.01% 3401
2018
Q2 		$23K Buy
+1,027
New +$21K ﹤0.01% 2343
2018
Q1 		– Sell
-776
Closed -$13K – 3215
2017
Q4 		$13K Buy
776
+654
+536% +$11.2K ﹤0.01% 2359
2017
Q3 		$2K Sell
122
-23
-16% -$386 ﹤0.01% 3543
2017
Q2 		$2K Buy
+145
New +$2.29K ﹤0.01% 2309
2017
Q1 		– Sell
-915
Closed -$15K – 3009
2016
Q4 		$15K Buy
+915
New +$15.3K ﹤0.01% 2361
2016
Q3 		– Sell
-482
Closed -$7K – 3586
2016
Q2 		$7K Buy
+482
New +$6.02K ﹤0.01% 3100
2016
Q1 		– Sell
-2,622
Closed -$32K – 4064
2015
Q4 		$32K Sell
2,622
-3,458
-57% -$42.6K 0.01% 817
2015
Q3 		$80K Buy
6,080
+2,914
+92% +$44K 0.01% 695
2015
Q2 		$52K Buy
3,166
+2,085
+193% +$34.6K ﹤0.01% 1322
2015
Q1 		$19K Buy
1,081
+414
+62% +$7.7K ﹤0.01% 2281
2014
Q4 		$13K Sell
667
-2,025
-75% -$34.3K ﹤0.01% 1894
2014
Q3 		$37K Buy
+2,692
New +$38.4K ﹤0.01% 1787
2014
Q2 		– Sell
-1,673
Closed -$26K – 3987
2014
Q1 		$26K Buy
1,673
+1,473
+737% +$24K ﹤0.01% 1633
2013
Q4 		$3K Sell
200
-1,246
-86% -$19.2K ﹤0.01% 3809
2013
Q3 		$19K Buy
+1,446
New +$17K ﹤0.01% 2715

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Tower Research Capital (TRC)'s ANGO Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its AngioDynamics (ANGO) stake by 6.5% in Q1 2026, buying an estimated $932 and bringing the position to 1,405 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #3642.

Tower Research Capital (TRC) first reported a position in ANGO in Q3 2013 and has held it in 43 quarters since. The position peaked at $475K in Q3 2020. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Tower Research Capital (TRC) held 1,405 shares of AngioDynamics worth $16K as of Q1 2026.
  • Tower Research Capital (TRC) bought 86 AngioDynamics shares in Q1 2026, an estimated $932.
  • AngioDynamics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3642 holding.
  • Tower Research Capital (TRC) first reported a position in AngioDynamics in Q3 2013 and has held it in 43 quarters since.
  • Tower Research Capital (TRC)'s AngioDynamics position peaked at $475K in Q3 2020.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.